Amanote Research

Amanote Research

    RegisterSign In

Commentaries & Analyses — Strategic Balancing of Patent and FDA Approval Processes to Maximize Market Exclusivity

Asia-Pacific Biotech News
doi 10.1142/s0219030303001782
Full Text
Open PDF
Abstract

Available in full text

Date

August 4, 2003

Authors
DENNIS S. FERNANDEZJAMES T. HUIE
Publisher

World Scientific Pub Co Pte Lt


Related search

Obinutuzumab Breaks Through to FDA Approval

Cancer Discovery
Oncology
2013English

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

FDA Approval of Obesity Drugs

JAMA - Journal of the American Medical Association
Medicine
2012English

Response to FDA Commissioner's Statement on Dsuvia Approval

Addiction
MedicinePsychiatryMental Health
2019English

Era of Faster FDA Drug Approval Has Also Seen Increased Black-Box Warnings and Market Withdrawals

Health Affairs
MedicineHealth Policy
2014English

From the FDA: Approval of Medical Devices to Be Accelerated

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

New FDA Drug Approval Policies and HIV Vaccine Development.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1990English

First CAR to Pass the Road Test: Tisagenlecleucel's Drive to FDA Approval

Clinical Cancer Research
Cancer ResearchOncology
2018English

Review of the FDA Premarket Approval Studies Comparing SMILE and LASIK

Journal of Refractive Surgery
OphthalmologySurgery
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy